Semmelweis University, Institute of Laboratory Medicine, Diagnostic Laboratory of Clinical Microbiology, Nagyvárad Tér 4, Budapest, 1089, Hungary.
Int J Med Microbiol. 2012 Nov;302(6):257-60. doi: 10.1016/j.ijmm.2012.05.003. Epub 2012 Jun 20.
In order to reveal colonization with multidrug-resistant bacteria early, routine screening is done on samples of all patients of the neonatal intensive care units at Semmelweis University, Hungary. Due to the extended-spectrum β-lactamase (ESBL) screening examinations, emergence of multidrug-resistant Enterobacter cloacae isolates was found with suspicion of clonal transmission, therefore active microbiological surveillance was initiated. The aim of our study was to characterize 60 E. cloacae isolates recovered in a 7-month period in 2010. MIC values of antibiotics were determined and ESBL and carbapenemase production was tested. Metallo-β-lactamase (MBL) genes, ESBL genes, and class-1 integrons were characterized, and the possible clonal relationship between isolates was investigated. The isolates showed increased MIC values for carbapenems and cephalosporins. All 60 E. cloacae strains recovered from 16 neonates proved to be VIM-4 MBL producers. Fifty-three strains were SHV-12 ESBL producers also. In all cases, the bla(VIM-4) gene was a part of class-1 integron, In238a. XbaI-macrorestriction analysis by pulsed-field gel electrophoresis (PFGE) revealed identical patterns for the isolates. Our study supports the importance of active microbiological surveillance as well as molecular epidemiology at the NICUs as a part of infection control.
为了早期发现耐多药细菌的定植,匈牙利塞梅尔维斯大学的新生儿重症监护病房对所有患者的样本进行常规筛查。由于进行了扩展谱β-内酰胺酶(ESBL)筛查检查,怀疑存在克隆传播,因此发现了耐多药阴沟肠杆菌分离株的出现,因此启动了主动微生物监测。我们的研究目的是在 2010 年的 7 个月期间对 60 株阴沟肠杆菌进行特征分析。测定了抗生素的 MIC 值,并检测了 ESBL 和碳青霉烯酶的产生。对金属β-内酰胺酶(MBL)基因、ESBL 基因和 1 类整合子进行了特征分析,并研究了分离株之间可能的克隆关系。分离株对碳青霉烯类和头孢菌素类的 MIC 值增加。从 16 名新生儿中分离出的 60 株阴沟肠杆菌均被证实为 VIM-4 MBL 产生菌。53 株也是 SHV-12 ESBL 产生菌。在所有情况下,bla(VIM-4)基因均位于 1 类整合子 In238a 中。XbaI 限制酶切图谱分析通过脉冲场凝胶电泳(PFGE)显示分离株具有相同的图谱。我们的研究支持了在新生儿重症监护病房进行主动微生物监测和分子流行病学作为感染控制的一部分的重要性。